| 5282 |
Centers for Disease Control and Prevention |
Html |
en |
2009 H1N1 Influenza Vaccine with Long-Dated Expiration Questions and Answers |
null |
| PHER funds | 0.30649 |
| long-expiry vaccine | 0.477663 |
| CDC | 0.244278 |
| seasonal vaccine | 0.739377 |
| trivalent influenza vaccine | 0.606499 |
| H1N1monovalent vaccine | 0.468427 |
| expired vaccine | 0.465777 |
| Recovery Program | 0.267109 |
| seasonal vaccine distribution | 0.525838 |
| influenza vaccine expiration | 0.599702 |
| H1N1 influenza activity | 0.353056 |
| cold chain integrity | 0.302372 |
| seasonal trivalent influenza | 0.375668 |
| state health departments | 0.298715 |
| influenza vaccine | 0.692965 |
| PM EDT | 0.273092 |
| early fall | 0.257868 |
| sufficient supply | 0.255604 |
| vaccination increase | 0.254759 |
| refrigerator storage | 0.256652 |
| Pasteur multi-dose vials | 0.327095 |
| direct communication | 0.25253 |
| H1N1 strain | 0.316858 |
| healthcare providers | 0.256888 |
| H1N1 vaccine supplies | 0.507032 |
|
| flu vaccine | 0.447523 |
| H1N1 Central Vaccine | 0.570231 |
| Sanofi Pasteur MDV | 0.335938 |
| robust supply | 0.252623 |
| H1N1 disease | 0.262761 |
| influenza A strain | 0.299158 |
| seasonal influenza vaccine | 0.681852 |
| trivalent vaccine | 0.571325 |
| event | 0.22955 |
| health care providers | 0.298075 |
| grantees | 0.240746 |
| high risk conditions | 0.297871 |
| resurgence | 0.242395 |
| seasonal  trivalent vaccine | 0.546047 |
| vaccine viability | 0.461118 |
| Sanofi Pasteur | 0.343634 |
| assured. States | 0.255477 |
| provider temperature logs | 0.299696 |
| vaccine | 0.922234 |
| 2010-11 seasonal vaccine | 0.554757 |
| 2010-2011 seasonal vaccine | 0.548774 |
| expiration dates | 0.322562 |
| viable vaccine | 0.466227 |
| time | 0.219489 |
|
CLICK HERE |
| 6444 |
Centers for Disease Control and Prevention |
Html |
en |
Announcements: Clinical Vaccinology Course - March 9-11, 2012 |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| mmwrq@cdc.gov. | 0.752831 |
| family physicians | 0.737674 |
| Course participants | 0.737359 |
| National Foundation | 0.741575 |
| U.S. Government Printing | 0.833689 |
| original MMWR paper | 0.831737 |
| infectious diseases | 0.872476 |
| interactive case presentations | 0.8544 |
| Human Services | 0.81936 |
| Emory University | 0.748865 |
| assistive technology | 0.75252 |
| new developments | 0.737882 |
| Clinical Vaccinology Course | 0.884413 |
| health-care professionals | 0.73934 |
| newly available vaccines | 0.94635 |
| latest information | 0.741959 |
| MMWR HTML versions | 0.83618 |
| U.S. Department | 0.817249 |
| MMWR readers | 0.735148 |
| character translation | 0.72055 |
| education credits | 0.734583 |
| nurse practitioners | 0.722367 |
| electronic PDF version | 0.822443 |
|
| hotel accommodations | 0.722671 |
| adult populations | 0.734637 |
| format errors | 0.722316 |
| disease prevention efforts | 0.844839 |
| health professionals | 0.74617 |
| vaccine program administrators | 0.851547 |
| Emory Vaccine Center | 0.874246 |
| subject line | 0.748749 |
| Contact GPO | 0.752043 |
| continued administration | 0.735355 |
| typeset documents | 0.728887 |
| trade names | 0.726701 |
| commercial sources | 0.726614 |
| official text | 0.719113 |
| infectious disease experts | 0.870307 |
| local public health | 0.854207 |
| Bethesda Avenue | 0.729696 |
| current prices | 0.72396 |
| non-CDC sites | 0.726563 |
| original paper copy | 0.829402 |
| physician assistants | 0.730936 |
| national organizations | 0.743125 |
| vaccine-preventable diseases | 0.749228 |
|
CLICK HERE |
| 6981 |
Centers for Disease Control and Prevention |
Html |
en |
Global Health - Mozambique |
null |
| strategic information | 0.512 |
| CDC | 0.978435 |
| endorsement | 0.282863 |
| access | 0.251364 |
| medical male circumcisions | 0.781724 |
| public health policies | 0.82987 |
| HIV/AIDS counseling | 0.560444 |
| antiretroviral treatment | 0.603272 |
| Content source | 0.489658 |
| HHS | 0.289441 |
| FY | 0.407604 |
| Mozambique | 0.400901 |
| transmission | 0.24737 |
| Notice | 0.257785 |
| children | 0.248855 |
| lab infrastructure | 0.521257 |
| Download Overview Fact | 0.765025 |
|
| CDC initiatives | 0.900676 |
| health systems | 0.504392 |
| HIV/AIDS care | 0.543303 |
| infants | 0.260379 |
| work | 0.252884 |
| testing | 0.252607 |
| HIV-positive pregnant women | 0.781042 |
| prevention programs | 0.512848 |
| TB/HIV care | 0.580332 |
| services | 0.256589 |
| improvement | 0.255483 |
| capacity development | 0.553043 |
| non-federal site | 0.533329 |
| partners | 0.257069 |
| provision | 0.332126 |
| blood safety | 0.521078 |
| antiretroviral drugs | 0.602311 |
|
CLICK HERE |
| 8276 |
Centers for Disease Control and Prevention |
Html |
en |
Preventing Chronic Disease | Recruitment and RetentionTechniques for Developing Faith-Based Research Partnerships, NewYork City, 2009-2012 - CDC |
Faith-based organizations are recognized as an influential venue for behavioral health interventions. However, less is known about efficient approaches for identifying and recruiting these organizations and about the processes that enable successful partnership. |
| FBO member | 0.696009 |
| larger FBO | 0.683734 |
| partnering FBO | 0.699932 |
| New York City | 0.66759 |
| Project SCALE | 0.661517 |
| South Bronx | 0.644593 |
| FBO | 0.927513 |
| FBO leadership | 0.716625 |
| behavioral health intervention | 0.633112 |
| study informational request | 0.626808 |
| 12-week pilot study | 0.633576 |
| study participation | 0.663135 |
| study materials | 0.635125 |
| Community United Methodist | 0.629534 |
| behavioral health interventions | 0.675876 |
| FBO’s leaders | 0.707489 |
| extra FBO activities | 0.752127 |
| external FBO activities | 0.751704 |
| physical activity strategies | 0.635721 |
| study recruitment | 0.654803 |
| intervention | 0.721308 |
| Abyssinian Baptist Church | 0.626714 |
| FBO leaders | 0.751507 |
| study | 0.927376 |
|
| FBO events | 0.681507 |
| spiritual leaders | 0.62952 |
| FBO members | 0.715345 |
| weight loss intervention | 0.638304 |
| FBO sites | 0.712871 |
| FBO’s infrastructure | 0.700379 |
| FBO’s membership | 0.684972 |
| faith-based organizations | 0.75875 |
| smaller FBO | 0.685775 |
| group orientation sessions | 0.654028 |
| community-based participatory research | 0.631825 |
| study planning meetings | 0.632666 |
| FBOs | 0.734429 |
| New York | 0.715119 |
| Cornell Medical College | 0.746393 |
| FBO activities | 0.760446 |
| Mental Health Center | 0.663463 |
| physical activity | 0.801143 |
| FBO membership | 0.699486 |
| study personnel | 0.68053 |
| United Methodist Church | 0.628502 |
| Metropolitan Community United | 0.629539 |
| Weill Cornell Medical | 0.694609 |
| study staff | 0.753657 |
|
CLICK HERE |
| 11113 |
Centers for Disease Control and Prevention |
Html |
en |
2008 National Report on Biochemical Indicators of Diet and Nutrition - Table 4.1 |
null |
| Estimate | 0.263867 |
| Total population | 0.303364 |
| urine concentrations | 0.567388 |
| Males | 0.431576 |
| Search Form Controls | 0.312863 |
| conf. interval | 0.88306 |
| creatinine | 0.325195 |
| Urinary equol | 0.258666 |
| file | 0.291111 |
| Geometric mean | 0.876941 |
| small cell size | 0.589609 |
| Urinary enterolactone | 0.258587 |
| Urinary O-desmethylangolensin | 0.258639 |
| Serum | 0.309554 |
| u.s. population | 0.587991 |
| Nutrition Examination Survey | 0.81028 |
| μg/g creatinine | 0.323763 |
| Biochemical Indicators | 0.263975 |
| National Report | 0.257026 |
| Tweet Share Compartir | 0.265254 |
| Urinary enterodiol | 0.258613 |
|
| greater uncertainty | 0.438278 |
| percentiles | 0.419781 |
| Mexican Americans | 0.404256 |
| Table | 0.447962 |
| non-hispanic whites | 0.392422 |
| Iodine Urinary iodine | 0.271037 |
| Urinary iodine | 0.986574 |
| Lignans Urinary genistein | 0.259871 |
| Fat-Soluble Vitamins | 0.251955 |
| Sample | 0.309185 |
| page options Skip | 0.260275 |
| Search Controls | 0.259881 |
| non-hispanic blacks | 0.397389 |
| total U.S. population | 0.30047 |
| National Health | 0.551723 |
| Urinary daidzein | 0.258692 |
| Compounds Serum folate | 0.252925 |
| Trace Elements | 0.254438 |
| Serum transferrin saturation | 0.254495 |
| Home Executive Summary | 0.25299 |
| page | 0.370529 |
|
CLICK HERE |
| 11129 |
Centers for Disease Control and Prevention |
Html |
en |
B Virus 'Specimen Collection and Detection | Herpes B | CDC |
In cases of B virus exposure and infection, specimens for virus culture and serologic testing should be obtained from the exposed person and, when feasible, from the source animal. |
| rapid diagnosis | 0.385188 |
| Antiviral research | 0.393454 |
| virus Resource Center | 0.980816 |
| viable B virus | 0.587739 |
| virus exposure | 0.670905 |
| virus serologic methods | 0.656347 |
| educational resources | 0.391635 |
| possible exposures | 0.388567 |
| PCR protocols | 0.409221 |
| treatment monitoring | 0.38923 |
| diagnostic laboratories | 0.395955 |
| therapy decisions | 0.379056 |
| real-time PCR method | 0.482871 |
| zoonotic infections | 0.404824 |
| diagnostic testing | 0.402248 |
| appropriate caution | 0.381632 |
| research laboratories | 0.387214 |
| HSV | 0.374129 |
| biosafety level | 0.386522 |
| up-to-date strategies | 0.388157 |
| zoonotically infected humans | 0.463563 |
| additional advantage | 0.377258 |
| wound area | 0.394417 |
| emergency information | 0.391552 |
| diagnostic methods | 0.390577 |
|
| National B virus | 0.776009 |
| herpes simplex virus | 0.678025 |
| cleansing protocol | 0.388933 |
| virus detection | 0.596585 |
| possible exposure event | 0.464416 |
| source animal | 0.398559 |
| direct detection | 0.378358 |
| PCR testing | 0.425627 |
| containment facility | 0.382191 |
| hazardous procedure | 0.375333 |
| Georgia State University | 0.478875 |
| Viral Immunology Center | 0.482395 |
| serologic testing | 0.400892 |
| current drug sensitivities | 0.468554 |
| sample collection | 0.397792 |
| PCR diagnostic assay | 0.488765 |
| specimens | 0.333544 |
| virus culture | 0.649989 |
| virus infection | 0.646484 |
| essential first step | 0.381281 |
| substantial levels | 0.385147 |
| natural host | 0.39015 |
| Direct culture | 0.381404 |
| diagnostic laboratory workers | 0.453594 |
|
CLICK HERE |
| 12158 |
Centers for Disease Control and Prevention |
Html |
en |
Meningitis | Lab Manual | Primary Culture and Presumptive Id | CDC |
Primary Culture and Presumptive Identification Laboratory Methods. |
| S. pneumoniae detection | 0.482955 |
| bacteria | 0.520582 |
| latex agglutination test | 0.502353 |
| Presumptive identification | 0.494365 |
| Gram stain | 0.738551 |
| rubber stopper | 0.4998 |
| well-mixed CSF sediment | 0.53915 |
| S. pneumoniae | 0.980197 |
| Typical CSF abnormalities | 0.531839 |
| Staphylococcus aureus | 0.502493 |
| chocolate agar plate | 0.507676 |
| CSF examination | 0.510582 |
| aerosolized N. meningitidis | 0.50851 |
| chocolate agar | 0.517866 |
| rapid diagnostic test | 0.494823 |
| S. pneumoniae colonies | 0.486169 |
| CSF supernatant | 0.511032 |
| package insert | 0.467076 |
| CSF specimen | 0.519951 |
| entire Gram stain | 0.470353 |
| CSF specimens | 0.545026 |
| colony morphology | 0.496515 |
| H. influenzae | 0.920171 |
| crystal violet dye | 0.481863 |
| primary culture | 0.673254 |
|
| N. meningitidis | 0.787895 |
| blood culture bottle | 0.713893 |
| MacConkey agar | 0.504927 |
| blood culture specimens | 0.471158 |
| primary culture media | 0.627452 |
| cap | 0.490028 |
| CSF | 0.695281 |
| T-I medium | 0.538713 |
| bacterial meningitis | 0.508862 |
| CSF sediment | 0.582286 |
| gram-positive bacteria | 0.497969 |
| microbiology laboratory | 0.568864 |
| gram-negative bacteria | 0.483306 |
| latex agglutination | 0.54648 |
| latex agglutination testing | 0.486395 |
| blood culture broth | 0.489011 |
| BAP | 0.511915 |
| unknown CSF | 0.508322 |
| inoculated blood culture | 0.481247 |
| well-characterized reference strain | 0.473929 |
| blood agar plate | 0.521021 |
| growth | 0.491487 |
| cytological examination | 0.472285 |
| H. influenzae forms | 0.487323 |
|
CLICK HERE |
| 12966 |
Centers for Disease Control and Prevention |
Html |
en |
Mental Health Mental Health Basics -Mental Health |
null |
| list Skip | 0.813375 |
| page options Skip | 0.996993 |
| dysregulation | 0.477252 |
| Diagnostic | 0.434972 |
| edition | 0.434788 |
| Statistical Manual | 0.603162 |
| navigation Skip | 0.817564 |
| mental disorders | 0.573346 |
| agitation | 0.46017 |
|
| psychomotor retardation | 0.644011 |
| time period | 0.590846 |
| pages | 0.434829 |
| Mental illnesses | 0.608636 |
| Mood disorders | 0.619671 |
| appetite | 0.455533 |
| commonly reports feeling | 0.774864 |
| behavior | 0.435155 |
| depressive episode | 0.608374 |
|
CLICK HERE |
| 13660 |
Centers for Disease Control and Prevention |
Html |
en |
School Start Times for Middle School and High School Students | United States, 2011 to 2012 School Year |
Please note: An erratum has been published for this article. To view the erratum, please click here. |
| Janet B. Croft | 0.469984 |
| public charter schools | 0.529146 |
| risk behaviors | 0.472712 |
| Adolescent sleep habits | 0.567282 |
| U.S. Department | 0.473096 |
| National Sleep Foundation | 0.622747 |
| school | 0.899746 |
| delayed start times | 0.605144 |
| school level | 0.509477 |
| poor sleep hygiene | 0.585847 |
| school districts | 0.504138 |
| school athletic programs | 0.502245 |
| a.m. | 0.51109 |
| public schools | 0.662869 |
| adolescents | 0.558243 |
| early start times | 0.628496 |
| average start time | 0.838888 |
| traditional public schools | 0.529226 |
| insufficient sleep | 0.933199 |
| start times | 0.704515 |
| U.S. high school | 0.584195 |
| unhealthy risk behaviors | 0.471774 |
| latest average school | 0.526669 |
| high schools | 0.844933 |
| public middle | 0.608051 |
|
| United States | 0.47388 |
| G. Wheaton | 0.471946 |
| sleep | 0.950958 |
| sufficient sleep | 0.681335 |
| average school night | 0.521356 |
| U.S. public middle | 0.602469 |
| practice good sleep | 0.580143 |
| individual school level | 0.50635 |
| earliest average school | 0.52324 |
| public health concern | 0.48331 |
| daily physical activity | 0.475694 |
| North Dakota | 0.540474 |
| entire school districts | 0.492913 |
| school nights | 0.466701 |
| high school students | 0.844651 |
| possible public health | 0.475208 |
| sleep objective | 0.529778 |
| average school | 0.546081 |
| public middle schools | 0.539953 |
| policy statement | 0.472305 |
| inadequate sleep | 0.527578 |
| Gabrielle A. Ferro | 0.473921 |
| sleep hygiene | 0.588001 |
| adequate sleep | 0.706089 |
|
CLICK HERE |
| 14059 |
Centers for Disease Control and Prevention |
Html |
es |
Enfermedad inflamatoria pélvica - Hoja informativa de los CDC |
Enfermedad inflamatoria pélvica: Hoja informativa de los CDC |
| Archivo Apple Quicktime | 0.789574 |
| pequeño aumento | 0.69808 |
| largo plazo | 0.693992 |
| Archivo RealPlayer | 0.684919 |
| Archivo Zip Comprimido | 0.784946 |
|
| Archivo Microsoft PowerPoint | 0.815824 |
| Archivo Adobe PDF | 0.789697 |
| Archivo Microsoft Excel | 0.788407 |
| Archivo Microsoft | 0.998714 |
| usa condones | 0.713153 |
|
CLICK HERE |